Tulassay Z, Mihaly E, Herszényi L. Microscopic colitis: a challenging disorder. Dig Dis. 2020. 38 (2):117-21. [Medline]. [Full Text].
Guagnozzi D, Landolfi S, Vicario M. Towards a new paradigm of microscopic colitis: incomplete and variant forms. World J Gastroenterol. 2016 Oct 14. 22(38):8459-71. [Medline]. [Full Text].
Genta RM, Sonnenberg A. The yield of colonic biopsy in the evaluation of chronic unexplained diarrhea. Eur J Gastroenterol Hepatol. 2015 Aug. 27(8):963-7. [Medline].
Park T, Cave D, Marshall C. Microscopic colitis: a review of etiology, treatment and refractory disease. World J Gastroenterol. 2015 Aug 7. 21(29):8804-10. [Medline]. [Full Text].
Pardi DS. Diagnosis and management of microscopic colitis. Am J Gastroenterol. 2017 Jan. 112(1):78-85. [Medline].
Lindstrom CG. 'Collagenous colitis' with watery diarrhoea--a new entity?. Pathol Eur. 1976. 11 (1):87-9. [Medline].
Freeman HJ, Weinstein WM, Shnitka TK, et al. Watery diarrhea syndrome associated with a lesion of the colonic basement membrane (CD)-lamina propria (LP) interface. Ann R Coll Phys Surg Can. 1976. 9:45.
Read NW, Krejs GJ, Read MG, Santa Ana CA, Morawski SG, Fordtran JS. Chronic diarrhea of unknown origin. Gastroenterology. 1980 Feb. 78 (2):264-71. [Medline].
Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol. 1989 Jan. 20 (1):18-28. [Medline].
[Guideline] Miehlke S, Guagnozzi D, Zabana Y, et al. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J. 2021 Feb 22. [Medline]. [Full Text].
Pisani LF, Tontini GE, Vecchi M, Pastorelli L. Microscopic colitis: What do we know about pathogenesis?. Inflamm Bowel Dis. 2016 Feb. 22(2):450-8. [Medline].
Fine KD, Do K, Schulte K, et al. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol. 2000 Aug. 95(8):1974-82. [Medline].
Fernandez-Banares F, Esteve M, Farre C, et al. Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis. Eur J Gastroenterol Hepatol. 2005 Dec. 17(12):1333-8. [Medline].
Sikander A, Sinha SK, Prasad KK, Rana SV. Association of serotonin transporter promoter polymorphism (5-HTTLPR) with microscopic colitis and ulcerative colitis. Dig Dis Sci. 2015 Apr. 60(4):887-94. [Medline].
Koskela RM, Karttunen TJ, Niemela SE, Lehtola JK, Bloigu RS, Karttunen RA. Cytokine gene polymorphism in microscopic colitis association with the IL-6-174 GG genotype. Eur J Gastroenterol Hepatol. 2011 Jul. 23(7):607-13. [Medline].
Fernandez-Banares F, Esteve M, Espinos JC, Rosinach M, Forne M, Salas A, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol. 2007 Feb. 102(2):324-30. [Medline].
Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004 Jun. 99(6):1175-90. [Medline].
Baert F, Wouters K, D'Haens G, et al. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut. 1999 Sep. 45(3):375-81. [Medline]. [Full Text].
Al Momani L, Balagoni H, Alomari M, et al. The association between smoking and both types of microscopic colitis: A systematic review and meta-analysis. Arab J Gastroenterol. 2020 Mar. 21(1):9-18. [Medline].
Yen EF, Pokhrel B, Du H, et al. Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis. 2012 Oct. 18(10):1835-41. [Medline].
Fernndez-Baares F, de Sousa MR, Salas A, et al, for the RECOMINA Project, GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa). Impact of current smoking on the clinical course of microscopic colitis. Inflamm Bowel Dis. 2013 Jun. 19(7):1470-6. [Medline].
Roth B, Gustafsson RJ, Jeppsson B, Manjer J, Ohlsson B. Smoking- and alcohol habits in relation to the clinical picture of women with microscopic colitis compared to controls. BMC Womens Health. 2014 Jan 23. 14:16. [Medline]. [Full Text].
Munch A, Tysk C, Bohr J, et al. Smoking status influences clinical outcome in collagenous colitis. J Crohns Colitis. 2016 Apr. 10(4):449-54. [Medline]. [Full Text].
Kandemir O, Utas C, Gonen O, et al. Colonic subepithelial collagenous thickening in diabetic patients. Dis Colon Rectum. 1995 Oct. 38(10):1097-100. [Medline].
Langner C, Aust D, Ensari A, et al, for the Working Group of Digestive Diseases of the European Society of Pathology (ESP) and the European Microscopic Colitis Group (EMCG). Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology. 2015 Apr. 66(5):613-26. [Medline].
Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005 Aug 15. 22(4):277-84. [Medline]. [Full Text].
Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 2015 May. 110(5):749-59. [Medline].
Tong J, Zheng Q, Zhang C, Lo R, Shen J, Ran Z. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015 Feb. 110(2):265-76; quiz 277. [Medline].
Townsend T, Campbell F, O'Toole P, Probert C. Microscopic colitis: diagnosis and management. Frontline Gastroenterol. 2019 Oct. 10(4):388-93. [Medline]. [Full Text].
Bohr J, Tysk C, Eriksson S, Abrahamsson H, Jarnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996 Dec. 39(6):846-51. [Medline]. [Full Text].
Christ AD, Meier R, Bauerfeind P, Wegmann W, Gyr K. [Simultaneous occurrence of lymphocytic gastritis and lymphocytic colitis with transition to collagenous colitis] [German]. Schweiz Med Wochenschr. 1993 Jul 31. 123(30):1487-90. [Medline].
O'Mahony S, Nawroz IM, Ferguson A. Coeliac disease and collagenous colitis. Postgrad Med J. 1990 Mar. 66(773):238-41. [Medline]. [Full Text].
Cotter TG, Binder M, Harper EP, Smyrk TC, Pardi DS. Optimization of a scoring system to predict microscopic colitis in a cohort of patients with chronic diarrhea. J Clin Gastroenterol. 2017 Mar. 51(3):228-34. [Medline].
Holstein A, Burmeister J, Plaschke A, Rosemeier D, Widjaja A, Egberts EH. Autoantibody profiles in microscopic colitis. J Gastroenterol Hepatol. 2006 Jun. 21(6):1016-20. [Medline].
von Arnim U, Wex T, Ganzert C, Schulz C, Malfertheiner P. Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome. Clin Exp Gastroenterol. 2016. 9:97-103. [Medline]. [Full Text].
Gunaltay S, Kumawat AK, Nyhlin N, et al. Enhanced levels of chemokines and their receptors in the colon of microscopic colitis patients indicate mixed immune cell recruitment. Mediators Inflamm. 2015. 2015:132458. [Medline]. [Full Text].
Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc. 2000 Mar. 51(3):318-26. [Medline].
[Guideline] Nguyen GC, Smalley WE, Vege SS, et al, for the Clinical Guidelines Committee. American Gastroenterological Association institute guideline on the medical management of microscopic colitis. Gastroenterology. 2016 Jan. 150(1):242-6; quiz e17-8. [Medline]. [Full Text].
American Gastroenterological Association. AGA Institute guideline on the management of microscopic colitis: clinical decision support tool. Gastroenterology. 2016 Jan. 150 (1):276. [Medline].
Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology. 2001 May. 120(6):1483-4. [Medline].
Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernandez-Banares F. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis. 2011 Dec. 5(6):612-8. [Medline]. [Full Text].
Munch A, Ignatova S, Strom M. Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scand J Gastroenterol. 2012 Jan. 47(1):59-63. [Medline].